BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hemophilia Alliance
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231109T130000
DTEND;TZID=America/New_York:20231109T140000
DTSTAMP:20260404T092958
CREATED:20230921T185243Z
LAST-MODIFIED:20230921T185243Z
UID:45676-1699534800-1699538400@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A Discussion from Genentech About Subcutaneous Prophylaxis Treatment for Hemophilia A
DESCRIPTION:Date: Thursday\, November 9\, 2023\nTime: 1:00pm – 2:00pm ET \n\n \nTITLE:\nLearn More About Subcutaneous Prophylaxis Treatment for Hemophilia A:  A Discussion on the Latest Data and Patient Management \nDESCRIPTION:\nPlease join us for an engaging webinar led by Ketna Mistry\, MD who will be sharing information on patients with hemophilia A with a subcutaneous prophylaxis including the latest clinical data.  Ther presentation will include pivotal efficacy and safety data\, joint health data\, data in infants\, and an overview of real-world experience.  Be sure to bring your questions to have them answered during the Q&A following the program! \nSPEAKER:\n\nKetna Mistry\, MD \nMedical Director\, Hematology & Rare Blood Disorders\, U.S. Medical Affairs; Genentech \nDr. Mistry has 25 years of experience in her medical career\, as a physician caring for patients and teacher at Emory University\, a researcher at CDC\, and currently as a medical director at Genentech.  She completed medical school at Tulane University and graduated with honors from UCLA for her bachelor’s degree in psychobiology. She completed her internship and residency in pediatrics at University of Texas in Houston.  She is passionate about teaching and sharing information so that patients and providers can make the best informed decision for their care.
URL:https://hemoalliance.org/alliance-events/a-discussion-from-genentech-about-subcutaneous-prophylaxis-treatment-for-hemophilia-a/
CATEGORIES:Members Only,Webinar
END:VEVENT
END:VCALENDAR